Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells

Open Access

Peer-reviewed

Research Article

Miao He,

Affiliation Department of anesthesia, The Second Hospital of Jilin University, Changchun, China
⨯
Zhaoying Yang,

Affiliation Department of breast surgery, China-Japan Union Hospital of Jilin University, Changchun, China
⨯
Le Zhang,

Affiliation Department of breast surgery, China-Japan Union Hospital of Jilin University, Changchun, China
⨯
Changlong Song,

Affiliation Department of breast surgery, China-Japan Union Hospital of Jilin University, Changchun, China
⨯
Youjun Li ,

* E-mail: xyzhangjlu@sina.com (XZ); youjun.li@yahoo.com (YL)

Affiliation Department of anatomy, Norman Bethune Health Science Center of Jilin University, Changchun, China
⨯
Xingyi Zhang

* E-mail: xyzhangjlu@sina.com (XZ); youjun.li@yahoo.com (YL)

Affiliation Department of thorax surgery, The Second Hospital of Jilin University, Changchun, China
⨯

Reader Comments (0)

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cell migration
Is the Subject Area "Cell migration" applicable to this article?

Thanks for your feedback.
EGFR signaling
Is the Subject Area "EGFR signaling" applicable to this article?

Thanks for your feedback.